PET Imaging of Serotonin Transporters with 4-[18F]-ADAM in a Parkinsonian Rat Model
Open Access
- 1 July 2013
- journal article
- Published by SAGE Publications in Cell Transplantation
- Vol. 22 (7), 1295-1305
- https://doi.org/10.3727/096368912x658683
Abstract
This study was undertaken to address the effects of fetal mesencephalic tissue transplantation on the serotonin system in a rat model of Parkinson's disease (PD) while also investigating the usefulness of 4-[18F]-ADAM (a serotonin transporter imaging agent) coupled with micro-PET for imaging serotonin transporters (SERTs). A PD model was induced by unilateral injection of 6-hydroxydopamine (6-OHDA) into the right medial forebrain bundle of the nigrostriatal pathway, while cell transplantation was performed via intrastriatal injection of mesencephalic brain tissue dissected from embryonic (E14) rats. The 4-[18F]-ADAM/micro-PET scanning was performed following both 6-OHDA lesioning and transplantation. Immunohistochemistry (IHC) studies were also performed following the final PET scan, and the results were compared to show a 17–43% decrease in the specific uptake ratio (SUR) and a 23–52% decrease in serotonin transporter immunoreactivity (SERT-ir) within various brain regions on the lesioned side. The number of methamphetamine-induced rotations also decreased significantly at the 4th week postgraft. In addition, striatal SUR and the SERT-ir levels were restored to 77% and 83% 5 weeks postgraft. These results suggest that Parkinson's disease also affects the serotonergic system, while both the dopaminergic and serotonergic systems can be partially restored in a rat model of PD after E14 mesencephalic tissue transplantation. In addition, we have also determined that 4-[18F]-ADAM/micro-PET can be used to detect serotonergic neuron loss, monitor the progress of Parkinson's disease, and oversee the effectiveness of therapy.Keywords
This publication has 44 references indexed in Scilit:
- In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's diseaseNuclear Medicine and Biology, 2010
- Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PETNeuroImage, 2010
- Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and 18F-FDOPA PET OutcomesJournal of Nuclear Medicine, 2009
- Evaluation of nigrostriatal damage and its change over weeks in a rat model of Parkinson's disease: small animal positron emission tomography studies with [11C]β-CFTNuclear Medicine and Biology, 2009
- Dual-isotope single-photon emission computed tomography for dopamine and serotonin transporters in normal and parkinsonian monkey brainsNuclear Medicine and Biology, 2009
- Reversal of Dopaminergic Degeneration in a Parkinsonian Rat following Micrografting of Human Bone Marrow-Derived Neural ProgenitorsCell Transplantation, 2009
- Validation of 4-[18F]-ADAM as a SERT imaging agent using micro-PET and autoradiographyNeuroImage, 2009
- Dopamine-Dependent Periadolescent Maturation of Corticostriatal Functional Connectivity in MouseJournal of Neuroscience, 2009
- 6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolismJournal of Neural Transmission, 2000
- Effect of 6-hydroxydopamine on murine hematopoietic stem cells: Enhanced cytotoxicity on megakaryocyte colony forming unitsLife Sciences, 1991